In comparing CHIP and carboplatin for the treatment of previously untreated metastatic colorectal cancer, Asbury et al. [62] reported clinical studies of 56 patients who were given treatment in each of the study’s two arms. Here, STUB1 is linked to metastatic colorectal cancer.